AbCellera Biologics Inc. ABCL Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s operating income?
- AbCellera Biologics Inc. (ABCL) reported operating income of -$57.52M in Q1 2026.
- How has AbCellera Biologics Inc.'s operating income changed year-over-year?
- AbCellera Biologics Inc.'s operating income increased by 8.2% year-over-year, from -$62.66M to -$57.52M.
- What is the long-term trend for AbCellera Biologics Inc.'s operating income?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s operating income has grown at a 2.0% compound annual growth rate (CAGR), from $204.5M to -$217.11M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.